11月 2025
- 首頁
- GeneSight
11月 2025GeneSight的市場佔有率分析
GeneSight Psychotropic is a pharmacogenomic test which means that it analyzes how your genes may affect medication outcomes. The GeneSight test analyzes clinically important genetic variations in your DNA. Results can inform your healthcare provider about how you may break down or respond to certain medications commonly prescribed to treat depression, anxiety, ADHD, and other psychiatric conditions.
GeneSight(包含公司地區)
查看更多網站流量與參與度資訊- genesight.com
GeneSight的熱門網域總造訪量
了解GeneSight市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
GeneSight的熱門網域平均造訪時長
分析GeneSight參與度指標。
過去 3 個月平均造訪時長
子公司細目
GeneSight的熱門網域平均頁面瀏覽量
了解GeneSight如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自GeneSight
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Genesight launched commercial PGx testing laboratory focused on psychotropic drugs on Jan 1st '06.In 2006, Myriad Genetics' predecessor company, Assurex Health, using technology licensed from Cincinnati Children's Hospital Medical Center and the Mayo Clinic, launched the first commercial PGx testing laboratory focused on psychotropic drugs.
4月 30, 2025閱讀更多
新聞Brookfield partnered with Genesight on Sep 2nd '23.Brookfield, CT- HIAAH, a mental healthcare provider sector leader, recently announced their partnership with GeneSight, a pharmacogenomic test provider, to provide accurate dosage information for certain medications.
9月 30, 2023閱讀更多
查看所有GeneSight信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。